--- title: "在周三的交易中，以美国存托凭证形式在美国交易的欧洲股票上涨" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/274844105.md" description: "在美国交易的欧洲股票的美国存托凭证上涨，S&P 欧洲精选 ADR 指数上涨 0.31%，达到 1,817.60。值得注意的涨幅包括西班牙电信（Telefonica）上涨 5% 和 DBV 科技（DBV Technologies）上涨 3.8%，而 Sequans 通信（Sequans Communications）下跌 6.7% 和 Evaxion 下跌 5.5% 则位于下跌榜单。从英国和爱尔兰来看，葛兰素史克（GSK）上涨 7.6% 和洲际酒店集团（InterContinental Hotels Group）上涨 4.7% 领涨，而 Biodexa 制药（Biodexa Pharmaceuticals）下跌 10% 和 Nucana 下跌 2.9% 则面临下滑。MT Newswires 不提供投资建议" datetime: "2026-02-04T16:13:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274844105.md) - [en](https://longbridge.com/en/news/274844105.md) - [zh-HK](https://longbridge.com/zh-HK/news/274844105.md) --- # 在周三的交易中，以美国存托凭证形式在美国交易的欧洲股票上涨 11:13 AM EST, 02/04/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.31% to 1,817.60 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by telecommunications operator Telefonica ( TEFOF ) and biopharmaceutical company DBV Technologies ( DBVT ) , which rose 5% and 3.8% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and telecommunications company Nokia ( NOK ) , which advanced 2.7% and 2.4% respectively. The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and biotech firm Evaxion ( EVAX ) , which fell 6.7% and 5.5% respectively. They were followed by pharmaceutical company Novo Nordisk ( NVO ) and internet browser company Opera (OPRA), which were down 4.4% and 2.3% respectively. From the UK and Ireland, the gainers were led by pharmaceutical company GSK (GSK) and hospitality company InterContinental Hotels Group ( IHG ) , which increased 7.6% and 4.7% respectively. They were followed by alcoholic beverage company Diageo ( DEO ) and telecommunications operator Vodafone Group ( VOD ) , which were up 4.1% and 2.8% respectively. The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and NuCana ( NCNA ) , which dropped 10% and 2.9% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and Bicycle Therapeutics ( BCYC ) , which lost 2% and 1.4% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### 相关股票 - [DBVT.US](https://longbridge.com/zh-CN/quote/DBVT.US.md) - [EVAX.US](https://longbridge.com/zh-CN/quote/EVAX.US.md) - [TEF.US](https://longbridge.com/zh-CN/quote/TEF.US.md) - [GSK.US](https://longbridge.com/zh-CN/quote/GSK.US.md) - [SQNS.US](https://longbridge.com/zh-CN/quote/SQNS.US.md) - [BDRX.US](https://longbridge.com/zh-CN/quote/BDRX.US.md) - [IHE.US](https://longbridge.com/zh-CN/quote/IHE.US.md) - [IHG.US](https://longbridge.com/zh-CN/quote/IHG.US.md) - [SPEU.US](https://longbridge.com/zh-CN/quote/SPEU.US.md) - [NCNA.US](https://longbridge.com/zh-CN/quote/NCNA.US.md) ## 相关资讯与研究 - [瑞银上调爵士制药评级：核心业务韧性强劲，新药 Ziihera 成增长引擎](https://longbridge.com/zh-CN/news/286920691.md) - [默沙东 ADC 药物达 III 期主要终点](https://longbridge.com/zh-CN/news/286929703.md) - [高盛：升中国生物制药目标价至 8.05 港元 评级 “买入” 引入 GSK 乙肝药](https://longbridge.com/zh-CN/news/286057558.md) - [正大天晴牵手 GSK，瞄准乙肝百亿美元赛道商业化棋局](https://longbridge.com/zh-CN/news/285900076.md) - [葛兰素史克 (LON:GSK) 的内部人士购买了价值 130.62 英镑的股票](https://longbridge.com/zh-CN/news/286511281.md)